Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis.

Abstract

INTRODUCTION:

Bisphosphonate (BF) therapy is strongly related to the occurrence of medication-related osteonecrosis of the jaw (ONJ). However, no previous study has evaluated if there are sex-related differences on the ONJ establishment together with bone biomechanical alterations, and if they could have a synergy with the ZA treatment.

MATERIALS AND METHODS:

This study aimed to analyze the physicochemical properties of mineralized tissues in a zoledronate (ZA)-related osteonecrosis mouse model, by a 2 × 2-factorial design, considering sex (female/male) and treatment (ZA/Saline) factors (n = 8/group). After three ZA (1.0 mg/kg) or saline administrations (days 0, 7, 14), the lower left second molar was extracted (day 42). Further ZA administration (day 49) and euthanasia (day 70) were conducted. After confirmation of ZA-induced jaw necrosis (histologic and microtomographic analysis), spectroscopic and mechanical parameters were assessed.

RESULTS:

ZA-treated groups presented lower bone density due to impaired healing of tooth extraction socket. Sex-related alterations were also observed, with lower bone density in females. Regarding biomechanical parameters, sex and treatment exerted independent influences. ZA, although decreasing flexural modulus and yield stress, increases stiffness mainly due to a higher bone volume. Females show less resistance to higher loads compared to males (considering dimension-independent parameters). Additionally, ZA increases crystallinity in bone and dental structure (p < 0.05). In summary, although strongly related to osteonecrosis occurrence, ZA modifies bone and dental mineral matrix, improving bone mechanical properties.

CONCLUSION:

Despite sex-dependent differences in bone biomechanics and density, osteonecrosis was established with no sex influence. No synergistic association between sex and treatment factors was observed in this study.

• Authors: Maria Elisa Quezado Lima-Verde, Maria Imaculada de Queiroz Rodrigues, Basílio Rodrigues Vieira, Francisco Tarcísio Guedes Lima-Verde Neto, Enzo Victorino Hernandez Agressott, Frederico Barbosa de Sousa, Alexandre Rocha Paschoal, Paulo Goberlânio de Barros Silva, Fabrício Bitu Sousa, Mário Rogério Lima Mota, Ana Paula Negreiros Nunes Alves
• Journal: Journal of bone and mineral metabolism (J Bone Miner Metab) Vol. 41 Issue 6 Pg. 760-771 (Nov 2023) ISSN: 1435-5604 [Electronic] Japan
• PMID: 37673837 (Publication Type: Journal Article)
• Copyright: © 2023. The Japanese Society Bone and Mineral Research.

Chemical References

• Zoledronic Acid
• Diphosphonates
• Bone Density Conservation Agents

Topics

• Mice
• Animals
• Male
• Female
• Zoledronic Acid (pharmacology)
• Bisphosphonate-Associated Osteonecrosis of the Jaw (pathology)
• Diphosphonates (adverse effects)
• Tooth Socket
• Bone Density
• Bone Density Conservation Agents (adverse effects)